Please try another search
WAKAMOTO PHARMACEUTICAL CO., LTD. is a Japan-based company mainly engaged in the manufacture and sale of ethical drugs such as gastrointestinal drugs and non-prescription drugs. The Company operates through four business segments. The Pharmaceuticals segment is involved in the manufacture and sale of innovator drugs, generic drugs and optiaid series supplements mainly in the ophthalmic field, as well as the commission of production and the sale of diagnostic drugs and raw materials in Japan. The Healthcare segment sales its core product Kawakami Wakamoto, the Avantbise series of medicated toothpastes that promote bad breath prevention based on evidence and Avantbise Oral Tablet mainly in the mail order business. The International segment is involved in the business related to the export of products and raw materials mainly in Asia and Europe, as well as the new license in and out business. The Real Estate Leasing segment is involved in the rental business of Coredo Muromachi.
Name | Age | Since | Title |
---|---|---|---|
Haruhisa Hirata | 68 | 2007 | Director |
Kimihiko Sato | 59 | 2014 | GM of Administration Division, Healthcare Business Division & Director |
Arata Igarashi | 66 | 2011 | President & Chairman |
Katsuyoshi Ejima | 71 | 2016 | Outside Independent Director |
Takehiko Tanigaki | 64 | 2022 | GM of Global Business Division & Sales Planning Department and Director |
Ikuro Kuwahara | 68 | 2023 | Independent Outside Director |
Hiroyoshi Kasai | 56 | 2022 | GM of Pharmaceutical Development Division & Product Strategy Department and Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review